- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/576 - ImmunoassayBiospecific binding assayMaterials therefor for hepatitis
Patent holdings for IPC class G01N 33/576
Total number of patents in this class: 430
10-year publication summary
|
27
|
30
|
36
|
27
|
18
|
22
|
23
|
10
|
12
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbott Laboratories | 2323 |
25 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3350 |
13 |
| F. Hoffmann-La Roche AG | 7861 |
11 |
| Roche Diagnostics Operations, Inc. | 1505 |
9 |
| Centre National de La Recherche Scientifique | 10855 |
8 |
| Universite D'angers | 171 |
8 |
| Advanced Life Science Institute, Inc. | 23 |
7 |
| Centre hospitalier universitaire D'angers | 58 |
7 |
| Fujirebio Inc. | 201 |
7 |
| Institut Pasteur de Lille | 183 |
6 |
| Morehouse School of Medicine | 157 |
6 |
| Sysmex Corporation | 1436 |
6 |
| Xiamen University | 558 |
6 |
| Roche Diagnostics GmbH | 2701 |
5 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3112 |
5 |
| The Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 60 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2966 |
5 |
| Assistance Publique - Hopitaux de Paris | 1035 |
4 |
| bioMerieux | 925 |
4 |
| Genfit | 281 |
4 |
| Other owners | 279 |